EUCTR2010-021591-28-IT进行中（未招募）不适用
A clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary intervention - Phoenix
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 10,900
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with at least 18 years of age with stable angina (SA), acute coronary syndrome without ST-segment elevation (NSTE-ACS) and myocardial infarction with ST-segment elevation (STEMI) requiring ICP and who have not previously taken an inhibitor of P2Y12.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization; 2.Eptifibatide and tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered =12 hours prior to randomization); 3.Abciximab usage within 7 days preceding randomization; 4.Receipt of fibrinolytic therapy in the 12 hours preceding randomization
研究者
相似试验
进行中（未招募）
不适用
A clinical trial comparing cangrelor to clopidogrel in subjects who require percutaneous coronary intervention. - NDSubjects with coronary atherosclerosis who require PCI (with or without stent).MedDRA version: 6.1Level: PTClassification code 10011076EUCTR2006-000192-14-ITTHE MEDICINES COMPANY UK9,000
进行中（未招募）
不适用
A clinical trial comparing cangrelor to clopidogrel standard of caretherapy in subjects who require percutaneous coronary interventioSubjects with coronary atheroschlerosis who require PCIMedDRA version: 14.1Level: LLTClassification code 10011076Term: Coronary artery atherosclerosisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-021591-28-CZThe Medicines Company10,900
进行中（未招募）
不适用
A clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary interventioSubjects with coronary atheroschlerosis who require PCIMedDRA version: 14.1Level: LLTClassification code 10011076Term: Coronary artery atherosclerosisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-021591-28-BGThe Medicines Company10,900
进行中（未招募）
不适用
A clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary interventioSubjects with coronary atheroschlerosis who require PCIMedDRA version: 14.1Level: LLTClassification code 10011076Term: Coronary artery atherosclerosisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-021591-28-DEThe Medicines Company10,900
进行中（未招募）
1 期
A clinical trial comparing cangrelor to clopidogrel in subjects who require percutaneous coronary intervention. - CHAMPION PCISubjects with coronary atherosclerosis who require percutaneous coronary intervention (PCI), with or without stent.MedDRA version: 9.1Level: LLTClassification code 10011093Term: Coronary atherosclerosisEUCTR2006-000192-14-GBThe Medicines Company9,000